PIB: A Score to Select Sorafenib Treatment Candidates for Hepatocellular Carcinoma in Resource-Limit...
PIB: A Score to Select Sorafenib Treatment Candidates for Hepatocellular Carcinoma in Resource-Limited Settings
About this item
Full title
Author / Creator
Publisher
Iran: Tehran Hepatitis Center
Journal title
Language
English
Formats
Publication information
Publisher
Iran: Tehran Hepatitis Center
Subjects
More information
Scope and Contents
Contents
Patient Characteristics of Patients with HCC on Sorafeniba Parameter All Patients (n = 127) Complete Survival Data (n = 86) P Value Age 65 (55 - 71) 64 (55 - 71) 0.3 Gender 0.4 Male 70 (89/127) 67 (58/86) Female 30 (38/127) 33 (28/86) Etiology of HCC Infectious 51 (65/127) 54 (47/86) 0.3 HBV + 15 (19/127) 15 (12/86) 0.8 HCV + 38 (48/127) 42 (36/86)...
Alternative Titles
Full title
PIB: A Score to Select Sorafenib Treatment Candidates for Hepatocellular Carcinoma in Resource-Limited Settings
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6243140
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6243140
Other Identifiers
ISSN
1735-143X
E-ISSN
1735-3408
DOI
10.5812/hepatmon.82345
